Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
1.294
-0.046 (-3.43%)
Feb 11, 2026, 1:57 PM EST - Market open
RANI Employees
As of December 31, 2024, Rani Therapeutics Holdings had 106 total employees, including 105 full-time and 1 part-time employees. The number of employees decreased by 34 or -24.29% compared to the previous year.
Employees
106
Change (1Y)
-34
Growth (1Y)
-24.29%
Revenue / Employee
$11,321
Profits / Employee
-$267,123
Market Cap
157.25M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 106 | -34 | -24.29% | 105 | 1 |
| Dec 31, 2023 | 140 | -23 | -14.11% | 140 | 0 |
| Dec 31, 2022 | 163 | 49 | 42.98% | 163 | 0 |
| Dec 31, 2021 | 114 | 43 | 60.56% | 114 | 0 |
| Sep 30, 2021 | 91 | 20 | 28.17% | 91 | 0 |
| Jun 30, 2021 | 78 | - | - | 78 | 0 |
| Mar 31, 2021 | 71 | - | - | 71 | 0 |
| Dec 31, 2020 | 71 | - | - | 71 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Sangamo Therapeutics | 183 |
| Zentalis Pharmaceuticals | 166 |
| Caribou Biosciences | 147 |
| Nkarta | 105 |
| Vaxart | 105 |
| Acumen Pharmaceuticals | 61 |
| Elicio Therapeutics | 32 |
| Corbus Pharmaceuticals Holdings | 28 |
RANI News
- 14 days ago - Rani Therapeutics Announces the Promotion of Alireza Javadi, Ph.D. to Chief Technical Officer - GlobeNewsWire
- 4 weeks ago - Rani Therapeutics Initiates Phase 1 Study of RT-114 RaniPill® for the Treatment of Obesity in Collaboration with ProGen - GlobeNewsWire
- 2 months ago - Rani Therapeutics to Participate in the Evercore Healthcare Conference - GlobeNewsWire
- 3 months ago - Rani Therapeutics Reports Third Quarter 2025 Financial Results; Provides Corporate Update - GlobeNewsWire
- 3 months ago - Rani Therapeutics to Present Preclinical Data on Oral Delivery of Semaglutide via the RaniPill® Capsule at ObesityWeek® 2025 - GlobeNewsWire
- 3 months ago - Rani Therapeutics Announces the Appointments of Abe Bassan and Vasudev Bailey, Ph.D. to Board of Directors - GlobeNewsWire
- 3 months ago - Rani Therapeutics Announces Closing of Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules - GlobeNewsWire
- 4 months ago - Rani Therapeutics: Initiating At Buy On Promising RaniPill Advancement With Chugai - Seeking Alpha